EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
-9.17%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$749M
AUM Growth
+$749M
(-23%)
Cap. Flow
-$79.3M
Cap. Flow
% of AUM
-10.59%
Top 10 Holdings %
Top 10 Hldgs %
75.79%
Holding
46
New
9
Increased
6
Reduced
13
Closed
11
Top Buys
| 1 |
Prothena Corp
PRTA
|
$68.2M |
| 2 |
Solid Biosciences
SLDB
|
$26M |
| 3 |
Sarepta Therapeutics
SRPT
|
$14.3M |
| 4 |
Exicure
XCUR
|
$14M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$9.76M |
Top Sells
| 1 |
CRISPR Therapeutics
CRSP
|
$75.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$43.1M |
| 3 |
Kura Oncology
KURA
|
$18.7M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$18.7M |
| 5 |
Gossamer Bio
GOSS
|
$17.1M |
Sector Composition
| 1 | Healthcare | 83.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Xencor
XNCR
$580M
| $84.4M | 10.66% | 2,501,557 +165,000 | +7% | +$5.57M |
|
|
2
Prothena Corp
PRTA
$441M
| $73.9M | 9.33% | 9,426,640 +8,703,340 | +1,203% | +$68.2M |
|
|
ONCE
3
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $69.3M | 8.75% | 714,789 +100,661 | +16% | +$9.76M |
|
|
4
Kura Oncology
KURA
$686M
| $61.3M | 7.74% | 4,041,953 -1,234,800 | -23% | -$18.7M |
|
5
argenx
ARGX
$43.6B
| $60.5M | 7.64% | 531,165 -50,000 | -9% | -$5.7M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $56.9M | 7.19% | 3,962,978 +646,571 | +19% | +$9.28M |
|
7
FibroGen
FGEN
$47.8M
| $47.8M | 6.04% | 1,293,807 -217,978 | -14% | -$8.06M |
|
8
Ironwood Pharmaceuticals
IRWD
$214M
| $40.1M | 5.06% | 4,671,408 | – | – |
|
|
MORF
9
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $39.1M | 4.94% | 2,161,520 -105,284 | -5% | -$1.91M |
|
|
10
Solid Biosciences
SLDB
$427M
| $34.6M | 4.36% | 3,342,691 +2,515,691 | +304% | +$26M |
|
|
PRVL
11
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $29.4M | 3.71% | 2,392,556 | – | – |
|
|
HARP
12
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $20M | 2.52% | 1,463,423 +115,000 | +9% | +$1.57M |
|
|
BCEL
13
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $18.1M | 2.29% | 1,481,411 -5,568 | -0.4% | -$68.2K |
|
|
CHMA
14
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.1M | 1.9% | 3,043,827 | – | – |
|
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $14.3M | 1.8% | +189,745 | New | +$14.3M |
|
|
16
Exicure
XCUR
$35.4M
| $14M | 1.76% | +5,515,225 | New | +$14M |
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $10.9M | 1.37% | 1,060,043 -76,000 | -7% | -$779K |
|
18
Cyclerion Therapeutics
CYCN
$7.91M
| $9.41M | 1.19% | 776,206 | – | – |
|
19
NextCure
NXTC
$13.5M
| $7.73M | 0.98% | +250,500 | New | +$7.73M |
|
20
Arcus Biosciences
RCUS
$1.13B
| $6.87M | 0.87% | 754,505 -733,700 | -49% | -$6.68M |
|
21
Curis
CRIS
$20.9M
| $6.68M | 0.84% | 2,982,208 | – | – |
|
22
Neurogene
NGNE
$264M
| $6.46M | 0.82% | 2,265,880 | – | – |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.45M | 0.44% | 44,221 -553,490 | -93% | -$43.1M |
|
24
Merus
MRUS
$4.98B
| $2.95M | 0.37% | +165,600 | New | +$2.95M |
|
|
25
Ultragenyx Pharmaceutical
RARE
$2.89B
| $2.63M | 0.33% | 61,554 -436,345 | -88% | -$18.7M |
|